These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 33784759)
41. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study). Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862 [TBL] [Abstract][Full Text] [Related]
42. Mesonephric adenocarcinoma of the uterine cervix: a case report with immunohistochemical and ultrastructural studies. Fukunaga M; Takahashi H; Yasuda M Pathol Res Pract; 2008; 204(9):671-6. PubMed ID: 18374498 [TBL] [Abstract][Full Text] [Related]
43. Mesonephric remnant hyperplasia of the cervix: a clinicopathologic analysis of 14 cases. Jones MA; Andrews J; Tarraza HM Gynecol Oncol; 1993 Apr; 49(1):41-7. PubMed ID: 8482559 [TBL] [Abstract][Full Text] [Related]
44. TUMORS OF MESONEPHRIC ORIGIN IN THE FEMALE GENITAL TRACT. VILLASANTA U Am J Obstet Gynecol; 1964 Jul; 89():680-90. PubMed ID: 14176919 [No Abstract] [Full Text] [Related]
45. Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases. Bagué S; Rodríguez IM; Prat J Am J Surg Pathol; 2004 May; 28(5):601-7. PubMed ID: 15105647 [TBL] [Abstract][Full Text] [Related]
46. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933 [TBL] [Abstract][Full Text] [Related]
47. Triple synchronous invasive malignancies of the female genital tract in a patient with a history of leukemia: A case report and review of the literature. Chiofalo B; Di Giuseppe J; Alessandrini L; Perin T; Giorda G; Canzonieri V; Sopracordevole F Pathol Res Pract; 2016 Jun; 212(6):573-7. PubMed ID: 26972418 [TBL] [Abstract][Full Text] [Related]
48. A comparative cytological and histological study of an endocervical Gartner duct carcinoma. Teter J Acta Pathol Microbiol Scand Suppl; 1972; 233():39-47. PubMed ID: 5074633 [No Abstract] [Full Text] [Related]
49. Mesonephric Adenocarcinoma and Mesonephric-like Adenocarcinoma of the Urinary Tract. Xing D; Liang SX; Gao FF; Epstein JI Mod Pathol; 2023 Jan; 36(1):100031. PubMed ID: 36788068 [TBL] [Abstract][Full Text] [Related]
50. A rare case of primary ovarian mesonephric adenocarcinoma and a review of the literature. Canbey C; Ceylan EC; Demir I; Solak HT; Erel E; Aybek OY; Senol T Ann Ital Chir; 2022 Mar; 11():. PubMed ID: 35348127 [TBL] [Abstract][Full Text] [Related]
51. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease]. Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410 [TBL] [Abstract][Full Text] [Related]
52. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix: a case report. Lu FH; Chen BF; Yang YC Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):436-40. PubMed ID: 9699398 [TBL] [Abstract][Full Text] [Related]
53. Mesonephric carcinomas and adenocarcinomas of the cervix in children. Fawcett KJ; Dockerty MB; Hunt AB J Pediatr; 1966 Jul; 69(1):104-10. PubMed ID: 5935751 [No Abstract] [Full Text] [Related]
54. Primary malignant melanoma of the uterine cervix: case report and review of the literature. Mousavi AS; Fakor F; Nazari Z; Ghaemmaghami F; Hashemi FA; Jamali M J Low Genit Tract Dis; 2006 Oct; 10(4):258-63. PubMed ID: 17012994 [TBL] [Abstract][Full Text] [Related]
55. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis. Höckel M; Hentschel B; Horn LC Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439 [TBL] [Abstract][Full Text] [Related]
56. Cervical implant from villoglandular endometrial adenocarcinoma masquerading as cervical villoglandular adenocarcinoma. Al-Nafussi A; Obafunwa J; Jordan LB; Fulton I; Martin C; Beattie G Int J Gynecol Cancer; 2002; 12(3):308-11. PubMed ID: 12060454 [TBL] [Abstract][Full Text] [Related]
57. Definition of compartment-based radical surgery in uterine cancer: modified radical hysterectomy in intermediate/high-risk endometrial cancer using peritoneal mesometrial resection (PMMR) by M Höckel translated to robotic surgery. Kimmig R; Aktas B; Buderath P; Wimberger P; Iannaccone A; Heubner M World J Surg Oncol; 2013 Aug; 11():198. PubMed ID: 23947937 [TBL] [Abstract][Full Text] [Related]
58. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy. Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336 [TBL] [Abstract][Full Text] [Related]
59. [Clear cell (mesonephric) adenocarcinoma of the cervical canal]. Gosh TE; Karseladze AI; Korotkikh IN Akush Ginekol (Mosk); 1982 Oct; (10):56-7. PubMed ID: 7181004 [No Abstract] [Full Text] [Related]
60. Pathologic quiz case: an incidentally detected mass of the uterine cervix. Mesonephric adenocarcinoma of the cervix. Angeles RM; August CZ; Weisenberg E Arch Pathol Lab Med; 2004 Oct; 128(10):1179-80. PubMed ID: 15387698 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]